SCHEMBL8367405

SCHEMBL8367405

CCC1=NCC(C)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2844613 0.77 NISCH (0.34)
SCHEMBL855414 0.76 NISCH (0.36)
SCHEMBL12018378 0.74
Hydrochloric Acid SCHEMBL3882896 0.70 ADRA2A (0.33)
SCHEMBL20026331 0.67
SCHEMBL23784767 0.67 ALDH1A1 (0.34)
SCHEMBL13049139 0.65
SCHEMBL5067966 0.65 KMT2A (0.37)
SCHEMBL13618510 0.64
SCHEMBL7758130 0.62 NISCH (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085154-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT JSR CORPORATION (JP) 2026-03-26 US disclosed
US-20250122404-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT JSR CORPORATION (JP) 2025-04-17 US disclosed
EP-4474427-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT JSR Corporation (JP) 2024-12-11 EP disclosed
EP-4392998-A1 ELECTRICALLY CONDUCTIVE ADHESIVE COMPOSITION FOR BONDING SOLAR CELLS Henkel AG & Co. KGaA (DE) 2024-07-03 EP disclosed
EP-4316814-A1 POLYMER, COMPOSITION, CURED PRODUCT, MULTILAYER BODY, AND ELECTRONIC COMPONENT JSR Corporation (JP) 2024-02-07 EP disclosed
WO-2023024071-A1 ELECTRICALLY CONDUCTIVE ADHESIVE COMPOSITION FOR BONDING SOLAR CELLS HENKEL AG & CO. KGAA (DE) 2023-03-02 WO disclosed
US-20160176865-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2016-06-23 US disclosed
US-20150290205-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2015-10-15 US disclosed
US-20130261117-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2013-10-03 US disclosed
US-8470818-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2013-06-25 US disclosed
US-7897776-B2 Sulfonamide containing compounds for treatment of inflammatory disorders SALUTRIA PHARMACEUTICALS LLC (US) 2011-03-01 US disclosed
US-20100331305-A1 OXO-HETEROCYCLE FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE GENENTECH, INC. (US) 2010-12-30 US disclosed
US-20090270454-A1 Sulfonamide containing compounds for treatment of inflammatory disorders CRABTREE ACQUISITION CO, LLC 2009-10-29 US disclosed
EP-0111073-B1 PROCESS FOR THE PREPARATION OF 2-IMIDAZOLINES BASF Aktiengesellschaft (DE) 1987-02-25 EP disclosed
EP-0111073-A1 Process for the preparation of 2-imidazolines BASF Aktiengesellschaft (DE) 1984-06-20 EP disclosed